Paul is a Chartered (UK) and European Patent Attorney with over 25 years of experience in the IP profession. A number of his clients have worked with him since he started in the profession and still do so to this day. His clients range from universities and SMEs to large multinational companies particularly in the biotechnology, chemistry and pharmaceutical fields. His University clients currently include Birmingham, Edinburgh, Dundee, Durham, Strathclyde and St. Andrews.

He has significant expertise in biologics including, antibody technology, cell therapies, RNAi and vaccines. Paul also carries out a significant amount of work in relation to molecular and in vitro diagnostics, medical devices, anaerobic digestion, drug delivery, cancer therapeutics, catalysis, nanotechnology and DNA technologies. He has experience of European Opposition and Appeal procedures, in particular, in the areas of biotechnology, molecular biology and chemistry. Paul also has considerable experience of filing and prosecuting SPC applications throughout Europe. As well as prosecution and opposition work, Paul provides strategic advice to ensure that his clients get the best out of their IP.

Paul has authored and/or edited a number of the firm's life sciences reports and other publications and is a regular speaker at bioscience conferences and has given many presentations and workshops to universities and other clients.

Paul was recommended in 2016 by IAM Patent 1000, which says that “he constantly provides excellent service”. He was recommended in the 2015 edition of Legal 500, and mentioned in 2016. For the last two consecutive years, he has also been listed as ‘IP Star’ by Managing Intellectual Property.

Paul was brought up and educated in Edinburgh. He obtained an honours degree in microbiology from the University of Glasgow, followed by a doctorate in molecular biology.